Follow the 노을 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 노을 has published 87 public disclosures. Market capitalisation: €37.4bn. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: 김미진. Every trade is accessible without an account.
87
Insider Decl.
0
Thresholds
€283,162
11 ops.
Buy Volume
€195,999
8 ops.
Sell Volume
31Σ signal
Buys €283,162€195,999 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 26,181 of 26,270 companies
4.2
score / 100
Value
3
Quality
5
FCF yld-65%
Earn yld-55%
EV/EBITDA·
ROE-110%
Gross mgn8.2%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
노을 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance patient health.